
New Diabetes Trial Offers Temporary Cure for Severe Type 1 Patients
A small stem cell trial using zimislecel by Vertex Pharmaceuticals has temporarily cured or significantly reduced insulin dependence in 10 out of 12 severe Type 1 diabetes patients, offering hope for future treatments.


